This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Platform Lists on NYSE After MacDermid Deal, Pershing Stake

The Leever Family and MacDermid

Platform's CEO Dan Leever began working at MacDermid in 1982. His family's roots with the company, however, trace back to the late 1930s.

Dan's father Harold Leever joined MacDermid in 1938 as its first research and development chemist and quickly rose through the ranks of the company, becoming CEO in the early 1940s. In 1959, Harold led an employee buyout of the company from its founder Archie J. MacDermid.

Dan Leever took over reins of MacDermid in 1990 as the company listed its shares on the New York Stock Exchange. In 2006, Leever, Joseph M. Silvestri of Court Square Capital Partners and private equity firm Weston Presidio bought MacDermid in a $1.3 billion leveraged buyout.

In 2011, Leever and MacDermid's private equity owners began exploring an initial public offering. In the end, Leever, a controlling shareholder in MacDermid, opted to join ranks with the likes of Martin Franklin, Nicolas Bergrruen and Pershing Square.

Platform estimates it paid approximately $925 million in cash for MacDermid owners and issued approximately $100 million of new equity to the sellers. The company also assumed over $750 million in MacDermid debt.

Leever expects to be among Platform's biggest shareholder after rolling 100% of his MacDermid equity into the company. "With Martin Franklin, my family and I have signed on with a new partner," Leever said.

MacDermid as a Platform for Acquisitions

Franklin said in an interview that shortly after creating Platform, the company and its bankers Barclays and Lazard initially looked into buying assets owned by French oil giant Total (TOT). The deal, however, wasn't actionable so Franklin instructed its bankers to look into acquisitions within the specialty chemicals space.

MacDermid quickly came to the top of their list of prospective acquisitions, given its profile of about $180 million in earnings before interest, taxes, depreciation and amortization (EBITDA) and low-capex. Franklin characterizes MacDermid an "asset light" high cash flow business that can help Platform with future acquisitions.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
BKW $35.50 0.00%
PAH $26.05 -2.07%
AAPL $126.41 -1.66%
FB $81.21 0.39%
GOOG $575.33 0.34%


DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs